Could an antibody boost colon cancer survival after surgery?
NCT ID NCT00002968
First seen Jan 05, 2026 · Last updated Apr 29, 2026 · Updated 21 times
Summary
This study looked at whether adding a lab-made antibody (edrecolomab) after surgery helps people with stage II colon cancer live longer. About 2,100 patients took part, with half getting the antibody and half just being watched. The goal was to see if the antibody could kill leftover cancer cells and prevent the cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCINOUS ADENOCARCINOMA OF THE COLON are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer and Leukemia Group B
Chicago, Illinois, 60606, United States
Conditions
Explore the condition pages connected to this study.